Geron(GERN) - 2023 Q2 - Earnings Call Presentation

OLIVIA BLOOM EVP, Chief Financial Officer Andrew J. Grethlein, Ph.D. EVP, Chief Operating Officer 3 Key Q2 Achievements Drive Geron Toward Potential Launch • Commercial planning on track for launch readiness in early 2024 5 • Expect to submit MAA in EU for LR MDS in Q4 2023 New IMerge Phase 3 Data and Analyses Presented at ASCO and EHA Highly statistically significant (p<0.001) and clinically meaningful increases in mean change in hemoglobin levels over time for imetelstat-treated patients versus placebo In ...